Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and Biological Products for Treatment; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and Biological Products for Treatment; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2836d ago.

Commenters (1)

• Advanced Medical Technology Associationtrade assoc.

  1 filing · confidence 97%